Mydecine Innovations Group Financial Overview
Mydecine Innovations Group's market cap is currently C$382.87K. The company's EPS TTM is C$0.06; its P/E ratio is 0.17; Mydecine Innovations Group is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
